Home › Markets › Health Care › RGNT

Regentis Biomaterials Ltd. (RGNT)

RGNT trades on NYSE in Health Care, Industrial Specialties. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.63
-0.31% on the day
Market cap
$11.4M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerRGNT on NYSE
SectorHealth Care
IndustryIndustrial Specialties
CountryIsrael
IPO year2025
SEC CIK0001912966
SEC industry codeOrthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated inL3

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1
POS AM2026-09-17
Latest annual report
ANNUAL REPORT
20-F2026-02-24
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-10-13

Source: SEC EDGAR submissions feed, 93 recent filings. All filings on EDGAR.

Peers in Industrial Specialties

TickerCompanyPriceDayMarket cap
FGIFGI Industries Ltd.$7.19-5.77%$13.9M
ADSEWADS-TEC ENERGY PLC Warrant$0.1901-20.76%$14.3M
CUPRCuprina Holdings (Cayman) Limited$1.90-7.77%$14.5M
HSCSHeartSciences Inc.$3.09-6.36%$15.0M
TLIHTen-League International Holdings Limited$5.72-0.09%$16.8M
LFWDLifeward Ltd.$6.10-1.93%$17.3M
CLGNCollPlant Biotechnologies Ltd$3.91-2.74%$7.4M
MLSSMilestone Scientific Inc.$0.3400-2.30%$30.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier